Quick Answer
Teladoc Health, Inc. reported Research And Development Expense of $277.92 million for the year ending 2025.
- Teladoc Health, Inc. showed a decrease of -9.6% in Research And Development Expense from 2024 to 2025.
- This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Teladoc Health, Inc.'s Research And Development Expense has grown by 7,768.7%.
- Historical annual values: Fiscal year 2025: $277.92 million | Fiscal year 2024: $307.27 million | Fiscal year 2023: $348.52 million | Fiscal year 2022: $333.63 million | Fiscal year 2021: $311.88 million | Fiscal year 2020: $164.94 million | Fiscal year 2019: $64.64 million | Fiscal year 2018: $54.37 million | Fiscal year 2017: $34.46 million | Fiscal year 2016: $21.82 million | Fiscal year 2015: $14.21 million | Fiscal year 2014: $7.57 million | Fiscal year 2013: $3.53 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: